OM Pharma Suisse SA
OM Pharma Suisse SA is a Originators company based in Meyrin (Geneva) recorded by Swissmedic as the authorisation holder for 34 human medicines. That places it 48 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Originators |
|---|---|
| City | Meyrin |
| Canton | Geneva |
| Authorisation holder | Yes |
| Medicines | 34 |
| Founded | 1937 |
| Employees | 201-1000 |
| Parent group | OM Pharma SA |
| Activity | Not available |
| Website | ompharma.com |
Medicines authorised in Switzerland
OM Pharma Suisse SA is recorded by Swissmedic as the authorisation holder for 34 human medicines. The table shows 34 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
34 of 34 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Anxiolit | 42127 | B | - | 1979-06-11 |
| Colo-Sol | 54234 | B | - | 1997-12-17 |
| Colosan mite mint | 43319 | D | - | 1980-06-30 |
| Doxocur 500 mg | 69172 | B | C05BX01 | 2023-01-26 |
| Faros 300 | 54292 | D | C01EB04 | 1997-12-19 |
| Feminelle | 56355 | D | - | 2004-09-30 |
| Gamunex 10% | 668 | B | - | 2005-10-26 |
| Hepa-S | 53355 | D | A05AX | 1996-09-06 |
| Jarsin 300 | 53148 | D | N06AX25 | 1997-01-30 |
| Jarsin 450 | 57009 | D | N06AX25 | 2005-12-15 |
| Jarsin Rx | 65841 | B | - | 2015-10-21 |
| Lithiofor | 38061 | A | N05AN01 | 1973-08-17 |
| Mg 5-Granoral 10mmol arôme mangue | 47600 | D | A12CC05 | 1986-08-12 |
| Mg 5-Longoral | 46144 | D | A12CC05 | 1984-09-18 |
| Mg 5-Oraleff | 49890 | D | A12CC05 | 1990-06-12 |
| Mg 5-Sulfat 10 % | 46768 | B | - | 1985-07-05 |
| Mucofor | 48587 | B | - | 1994-06-17 |
| Mucofor | 48590 | B | - | 1994-06-17 |
| Mucofor 150 mg | 48589 | B | R05CB15 | 1994-06-17 |
| Mutaflor | 684 | B | A07FA | 2005-02-17 |
| Oprane | 56250 | D | G02CX03 | 2002-09-30 |
| Prolastin | 697 | B | B02AB02 | 2006-01-19 |
| Prolastin-C Liquid 1000 mg/20 ml | 69448 | B | B02AB02 | 2024-11-25 |
| Sabcaps | 54823 | D | G04CX02 | 1999-12-03 |
| Sedonium | 55343 | D | N05CM09 | 2000-02-22 |
| Symfona 120 mg | 52408 | B | N06DX02 | 1993-05-27 |
| Symfona 240 mg | 63137 | B | N06DX02 | 2015-08-04 |
| Symfonel 120 mg | 57427 | D | N06DX02 | 2005-10-27 |
| Symfonel 240 mg | 63138 | D | - | 2016-01-22 |
| Trittico 50 mg | 46559 | B | N06AX05 | 1985-04-01 |
| Trittico retard | 57786 | B | N06AX05 | 2010-01-22 |
| Trittico Uno 150 mg | 66656 | B | N06AX05 | 2019-06-13 |
| Viferol D3 100'000 UI / ml | 65253 | B | A11CC05 | 2016-03-03 |
| Viferol D3 25'000 U.I./ml | 67173 | B | A11CC05 | 2020-03-18 |
Frequently asked questions
How many medicines does OM Pharma Suisse SA have authorised in Switzerland?
OM Pharma Suisse SA is recorded by Swissmedic as the authorisation holder for 34 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is OM Pharma Suisse SA based?
The Swiss location recorded for OM Pharma Suisse SA is Meyrin, Geneva.
Is OM Pharma Suisse SA a Swissmedic authorisation holder?
Yes. OM Pharma Suisse SA appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.